[
  {
    "criterion": "Provides information on the success rates of fecal microbiota transplantation (FMT) in treating recurrent C. difficile infections.",
    "axis": "completeness",
    "point": 9
  },
  {
    "criterion": "Mentions the importance of rigorous donor screening in FMT to minimize infection risk.",
    "axis": "accuracy",
    "point": 8
  },
  {
    "criterion": "Correctly explains the difference in success rates between FMT and vancomycin-based regimens in treating recurrent C. difficile infections.",
    "axis": "accuracy",
    "point": 9
  },
  {
    "criterion": "Asks for clarification on the user's question about potential long-term side effects.",
    "axis": "context_awareness",
    "point": 5
  },
  {
    "criterion": "Provides a clear and concise explanation of the benefits and potential risks of FMT.",
    "axis": "communication_quality",
    "point": 8
  },
  {
    "criterion": "Does not provide misleading information about the effectiveness of FMT in treating recurrent C. difficile infections.",
    "axis": "accuracy",
    "point": 9
  },
  {
    "criterion": "Provides references or supporting data for the claims made about FMT.",
    "axis": "completeness",
    "point": 8
  },
  {
    "criterion": "Does not recommend FMT as a replacement for established treatments for C. difficile infections.",
    "axis": "instruction_following",
    "point": 5
  },
  {
    "criterion": "Mentions the importance of consulting a healthcare professional before undergoing FMT.",
    "axis": "context_awareness",
    "point": 8
  }
]